Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
3.070
-0.100 (-3.15%)
At close: Oct 3, 2025, 4:00 PM EDT
3.130
+0.060 (1.95%)
After-hours: Oct 3, 2025, 7:58 PM EDT
Microbot Medical Employees
Microbot Medical had 20 employees as of December 31, 2024. The number of employees decreased by 2 or -9.09% compared to the previous year.
Employees
20
Change (1Y)
-2
Growth (1Y)
-9.09%
Revenue / Employee
n/a
Profits / Employee
-$635,400
Market Cap
162.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20 | -2 | -9.09% |
Dec 31, 2023 | 22 | 4 | 22.22% |
Dec 31, 2022 | 18 | -2 | -10.00% |
Dec 31, 2021 | 20 | 6 | 42.86% |
Dec 31, 2020 | 14 | 3 | 27.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBOT News
- 3 days ago - Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio - GlobeNewsWire
- 11 days ago - Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System - GlobeNewsWire
- 18 days ago - Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - GlobeNewsWire
- 19 days ago - Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds - GlobeNewsWire
- 25 days ago - REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference - GlobeNewsWire
- 26 days ago - Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System - GlobeNewsWire
- 5 weeks ago - Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst - Seeking Alpha
- 6 weeks ago - Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications - GlobeNewsWire